The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Significance of Hyperuricemia on the Early Detection of Renal Failure in a Cohort of Screened Subjects.
Open accessAbstract
A high level of serum creatinine (S-Cr) is a predictor of end-stage renal disease (ESRD), but only a few studies have investigated the prevalence of high S-Cr and its correlates in a large population. We analyzed the data collected from 6,403 subjects (4,222 men and 2,181 women) who participated in the Okinawa General Health Maintenance Association (OGHMA) screening both at 1997 and 1999. The computer-saved data included sex, age, blood chemistries, blood pressure, medical histories, and lifestyles. Multivariate Cox proportional hazard analyses were performed to identify the correlates of developing high S-Cr levels: > or = 1.4 mg/dl in men and > or = 1.2 mg/dl in women. The prevalence of high S-Cr was 3.0% (N=193), which was 4.1% in men (N=175) and 0.8% in women (N=18), and increased with age in both sexes at the 1997 screening. Among those who showed normal levels of S-Cr in 1997 (N=6,210), 241 subjects (223 men and 18 women) developed high S-Cr. The 2-year cumulative incidence of high S-Cr was 5.5% in men and 0.8% in women. Other than sex, serum uric acid was the most significant correlate for developing high S-Cr. The adjusted relative risk (95% confidence interval) of those with serum uric acid 8.0 mg/dl and over was 2.91 (1.79-4.75) in men and 10.39 (1.91-56.62) in women when compared to those with serum uric acid less than 5.0 mg/dl. Prevalence of high levels of S-Cr was relatively high in men. Other than gender, serum uric acid was a significant positive correlate of developing high S-Cr in this sample of the Japanese population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,663
Shulman, N. B., Ford, C. E., Hall, W. D., Blaufox, M. D., Simon, D., Langford, H. G., & Schneider, K. A. (1989) · Hypertension · doi:10.1161/01.hyp.13.5_suppl.i80 · Cited by 676
Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey
Jones, C., McQuillan, G., Kusek, J., Eberhardt, M., Herman, W., Coresh, J., Salive, M., Jones, C., & Agodoa, L. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70074-5 · Cited by 572
The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke
Sacco, R. L. (1999) · JAMA · doi:10.1001/jama.281.1.53 · Cited by 531
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Alderman, M. H., Cohen, H., Madhavan, S., & Kivlighn, S. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.144 · Cited by 441
Human Body Composition and the Epidemiology of Chronic Disease
Baumgartner, R. N., Heymsfield, S. B., & Roche, A. F. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00124.x · Cited by 413
The impact of gender on the progression of chronic renal disease
Silbiger, S. R., & Neugarten, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90119-1 · Cited by 393
Risk of developing end-stage renal disease in a cohort of mass screening
Iseki, K., Iseki, C., Ikemiya, Y., & Fukiyama, K. (1996) · Kidney International · doi:10.1038/ki.1996.111 · Cited by 342
Self-citationChronic progressive renal disease: Rate of change of serum creatinine concentration
Rutherford, W. E., Blondin, J., Miller, J. P., Greenwalt, A. S., & Vavra, J. D. (1977) · Kidney International · doi:10.1038/ki.1977.8 · Cited by 220
Cited by
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D.-H., Gersch, M. S., Benner, S., & Sánchez-Lozada, L. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.899 · Cited by 1,075
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Elevated Uric Acid Increases the Risk for Kidney Disease
Obermayr, R. P., Temml, C., Gutjahr, G., Knechtelsdorfer, M., Oberbauer, R., & Klauser-Braun, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010080 · Cited by 647
Sanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00074.x · Cited by 556
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K., & Takishita, S. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00934-5 · Cited by 526
Self-citationHypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Johnson, R. J., Perez-Pozo, S. E., Sautin, Y. Y., Manitius, J., Sanchez-Lozada, L. G., Feig, D. I., Shafiu, M., Segal, M., Glassock, R. J., Shimada, M., et al. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0033 · Cited by 505
Uric acid and cardiovascular disease
Ndrepepa, G. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.046 · Cited by 498
Uric Acid and Incident Kidney Disease in the Community
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101075 · Cited by 462
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
Uric acid, hyperuricemia and vascular diseases
Jin, M. (2012) · Frontiers in Bioscience · doi:10.2741/3950 · Cited by 406
Chino, Y., Samukawa, Y., Sakai, S., Nakai, Y., Yamaguchi, J., Nakanishi, T., & Tamai, I. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1909 · Cited by 389
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
Metabolomic Analysis of Livers and Serum from High-Fat Diet Induced Obese Mice
Kim, H.-J., Kim, J. H., Noh, S., Hur, H. J., Sung, M. J., Hwang, J.-T., Park, J. H., Yang, H. J., Kim, M.-S., Kwon, D. Y., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr100892r · Cited by 376
Kanbay, M., Ozkara, A., Selcoki, Y., Isik, B., Turgut, F., Bavbek, N., Uz, E., Akcay, A., Yigitoglu, R., & Covic, A. (2007) · International Urology and Nephrology · doi:10.1007/s11255-007-9253-3 · Cited by 325
Sircar, D., Chatterjee, S., Waikhom, R., Golay, V., Raychaudhury, A., Chatterjee, S., & Pandey, R. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.017 · Cited by 314
Mild hyperuricemia induces glomerular hypertension in normal rats
Sánchez-Lozada, L. G., Tapia, E., Avila-Casado, C., Soto, V., Franco, M., Santamaría, J., Nakagawa, T., Rodríguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00170.2002 · Cited by 297
Role of uric acid in hypertension, renal disease, and metabolic syndrome.
Heinig, M., & Johnson, R. J. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.12.1059 · Cited by 291
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
Taal, M. W., & Brenner, B. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001794 · Cited by 282
Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?
Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sánchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010063 · Cited by 280
Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc11-1346 · Cited by 274
Soltani, Z., Rasheed, K., Kapusta, D. R., & Reisin, E. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0344-5 · Cited by 272
Uric Acid as a Target of Therapy in CKD
Jalal, D. I., Chonchol, M., Chen, W., & Targher, G. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.021 · Cited by 268
Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Bellomo, G., Venanzi, S., Verdura, C., Saronio, P., Esposito, A., & Timio, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.019 · Cited by 260
Inactivation of Nitric Oxide by Uric Acid
Gersch, C., Palii, S. P., Kim, K. M., Angerhofer, A., Johnson, R. J., & Henderson, G. N. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802257952 · Cited by 253
Metadata
- Authors
- ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S.
- Venue
- Hypertension Research
- Publisher
- Japanese Society of Hypertension
- Published
- 2001
- Volume
- 24
- Issue
- 6
- Pages
- 691-697
- ISSN
- 0916-9636 (ISSN-L)
- OpenAlex
- W2048113580
- Cited by
- 386
- References
- 27
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.